Małgorzata Burzyńska | Biomedicines | Research Excellence Award

Published on by TOT Awards

Assist. Prof. Dr. Małgorzata Burzyńska | Biomedicines | Research Excellence Award

Wroclaw Medical University | Poland

Assist. Prof. Dr. Małgorzata Burzyńska is an Assistant Professor at the Wroclaw Medical University, specializing in anesthesiology and intensive care. With over two decades of clinical experience, her expertise focuses on severe central nervous system pathologies, particularly traumatic brain injury and aneurysmal subarachnoid hemorrhage. She has led and contributed to multiple nationally funded research projects on cerebral autoregulation, early brain injury, and neurocritical care monitoring, advancing understanding of neurological complications and patient outcomes. Dr. Burzyńska actively collaborates with biomedical engineering and signal processing groups, fostering interdisciplinary innovation. As a lecturer and frequent speaker at international conferences, she contributes to postgraduate education and professional development. Her work supports improved critical care strategies, enhancing survival and quality of life for patients with life-threatening neurological conditions.

Citation Metrics (Scopus)

300
225
150
75
0

Citations
280

h-index
10

Documents
29

Citations

h-index

Documents

Featured Publications

Adrianna Lebiedzińska, Małgorzata Burzyńska, Jowita Woźniak, Waldemar Goździk (2026).
The Prognostic Significance of Low-Triiodothyronine Syndrome in Aneurysmal Subarachnoid Hemorrhage
Biomedicines | Journal Article · 2026

Agnieszka Uryga, Marek Czosnyka, Magdalena Kasprowicz, Małgorzata Burzyńska, Barbara Dragan, Karol Budohoski, Nathalie Nasr (2025). Can ‘noisy data’ perform as well as ‘clean data’ in outcome modeling after aneurysmal subarachnoid haemorrhage?
Autonomic Neuroscience | Journal Article · 2025

Małgorzata Burzyńska, Jowita Woźniak, Piotr Urbański, Jarosław Kędziora, Rafał Załuski, Waldemar Goździk, Agnieszka Uryga (2025).
Heart Rate Variability and Cerebral Autoregulation in Patients with Traumatic Brain Injury with Paroxysmal Sympathetic Hyperactivity Syndrome
Neurocritical Care | Journal Article · 2025

Małgorzata Burzyńska (2025).
Nosocomial Infection after Aneurysmal Subarachnoid Hemorrhage
Conference: Postępy w Anestezjologii i Intensywnej Terapii | Conference Paper · 2025

Małgorzata Burzyńska (2025).
Relationship between Autonomic Nervous System Activity, Cerebral Autoregulation and Brain Biomarkers after Traumatic Brain Injury
Conference: Postępy w Anestezjologii i Intensywnej Terapii | Conference Paper · 2025

Liu Wenyi | Health Sciences | Best Researcher Award

Published on by TOT Awards

Dr. Liu Wenyi | Health Sciences | Best Researcher Award

Cancer Hospital Chinese Academy of Medical Sciences | China

Dr. Liu Wenyi is a thoracic-surgery specialist whose research focuses on advanced treatments for thoracic malignancies especially esophageal and lung cancers emphasising organ-preservation strategies, neoadjuvant chemo-/chemo-immunotherapy, imaging- and machine-learning-based response assessment, and translational biomarkers for surgical decision-making. His work has contributed to the evolving paradigm of less-invasive surgery and more personalised multimodal care. For example, his recent narrative review “Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions” is a state-of-the-field synthesis published in Cancers  highlighting novel surveillance-based approaches in esophageal squamous cell carcinoma. His Google Scholar/Scopus profile indicates approximately 10 publications and a current h-index of 5 (citations ~80) under his name. This volume reflects a mid-career emerging investigator whose trajectory is marked by high-impact topics (thoracic oncology, immunotherapy, AI-enabled imaging) and whose top publications already appear in high-visibility journals. Dr. Liu’s work is characterized by integrating minimally invasive surgical techniques, cutting-edge neoadjuvant systemic treatments and advanced predictive modelling to stratify patients for surgical risk and organ-sparing pathways thus contributing to both improved patient quality of life and optimized oncologic outcomes.His outstanding contributions to clinical innovation and scientific research excellence reflect strong merit for recognition under the Best Researcher Award .

Publication Profile

Orcid

Featured Publications

Liu, W., Guo, X., Zhao, H., Yu, X., Wang, C., Du, L., Wang, F., & Mu, J. (2020). Mediastinoscopy-assisted transhiatal esophagectomy versus thoraco-laparoscopic esophagectomy for esophageal cancer: A single-center initial experience. Journal of Thoracic Disease, 12(9), 4908-4914.

Liu, W., Tang, J., Li, X., Gong, L., Yang, D., Yin, H., Wang, W., & Zhang, B. (2025). Reduction in surgical scope after neoadjuvant chemotherapy and immunotherapy for non-small cell lung cancer. Oncology Letters, 30(5), 501.

Liu, W., Sui, Z., Wang, C., Deng, Y., Cai, S., Jia, R., Yu, Z., Kang, M., & Zhang, B. (2025). Nomogram for predicting pathological complete response to neoadjuvant chemoimmunotherapy in patients with resectable non-small cell lung cancer. Frontiers in Cell and Developmental Biology, 13, 1679782.

Hong, Z., Xie, S., Xu, H., Ke, S., Liu, W., Huang, S., Chen, S., Xie, J., Xu, J., & Kang, M. (2025). Major pathologic response as a prognostic surrogate in esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy/chemoimmunotherapy: A multi-center cohort study. European Journal of Surgical Oncology, 51(2), 109500.

Liu, W., Zhang, B., Wang, C., Yu, X., Du, L., Yu, Z., & Kang, M. (2025). Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions. Cancers, 17(21), 3559.